Apellis Pharmaceuticals(us:APLS)
22.68
+3.70%
Updated on 2025-04-02
Open:21.77
Close:22.68
High:23.77
Low:21.77
Prev Close:21.87
Volume:4.91M
Turnover:111.54M
Turnover Ratio:3.91%
Shares:125.52M
MarketCap:2.85B
About Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.
Company Name: Apellis Pharmaceuticals
Address: 100 5th Avenue
Employees: 706
Fiscar Year: 12-31
IPO Date: 2017-11-09
Website: http://www.apellis.com
CIK: 1492422
View all SEC Filings
About
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.
Address:100 5th Avenue
Website:http://www.apellis.com
Market Movers